Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
A two-step algorithm that incorporates the liver stiffness measurement hepatocellular carcinoma (LSM-HCC) score and enhanced liver fibrosis (ELF) score appears to improve the accuracy of predicting HCC in chronic hepatitis B (CHB) patients after antiviral treatment, according to a study from Hong Kong.
Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.
The low uptake of the human papillomavirus (HPV) vaccine in the US and strategies to improve HPV vaccine coverage were highlighted in two studies presented at the Pediatric Academic Societies annual meeting (PAS 2019).
The addition of the first-in-class direct lytic agent exebacase (lysin CF-301) to standard-of-care (SOC) antibiotics demonstrated efficacy against Staphylococcus aureus bacteraemia (SAB), particularly difficult-to-treat methicillin-resistant SA (MRSA), compared with SOC antibiotics alone, according to the results of a phase II trial presented at ECCMID 2019.
The novel human monoclonal antibody suvratoxumab yielded a trend toward reducing the incidence of Staphylococcus aureus pneumonia (SAP) in high-risk, mechanically-ventilated intensive care unit (MV ICU) patients with an acceptable safety profile, according to data from the phase II SAATELLITE* trial presented at ECCMID 2019.
Insemination with semen positive for human papillomavirus (HPV) virions is four times less likely to result in clinical pregnancies compared with HPV-negative sperm, a study has found.
The selective cap-dependent endonuclease inhibitor baloxavir marboxil (hereafter baloxavir) effectively improves influenza symptoms in adolescent patients and those at high risk for influenza complications, according to two subanalyses of the CAPSTONE studies presented at ECCMID 2019.
Special Reports
At the 40th Malaysian Paediatric Association Annual Congress held on 6 September 2018 at the Ipoh Convention Centre, Dr Yong Junina Fadzil discussed the applications of a hexavalent vaccine in optimizing paediatric vaccination schedules. Meanwhile, Dato’ Dr Musa Mohd Nordin shared his insights into the paediatric influenza ‘landscape’ in the region and highlighted the importance of regularly vaccinating paediatric patients.
SKYCELLFLU – Inactivated quadrivalent influenza vaccine (inj) 0.5 mL - AJ Biologics
Influenza is a highly contagious viral disease, which is primarily spread through water droplets containing strains of the virus. Dr Leong Chee Loon shares his insights into the management of influenza in Malaysia, highlighting the importance of improving vaccination coverage in populations at high-risk of influenza-related complications, such as elderly patients and healthcare practitioners.
ZEPATIER - Elbasvir 50 mg, grazoprevir 100 mg FC tab - Merck Sharp & Dohme
At the 13th Asian Congress of Paediatric Nephrology 2017 in conjunction with the 39th Malaysian Paediatric Association Annual Congress, Dr Wanatpreeya Phongsamart spoke on the importance of influenza vaccination in children, highlighting the role of quadrivalent influenza vaccine (QIV) in providing a broader protection against influenza. Meanwhile, Emeritus Professor Somsak Lolekha shared his insights into the effectiveness of a hexavalent vaccine in paediatric immunization, and discussed its role in the Malaysian paediatric immunization schedule.
At a continuing medical education webcast hosted by GlaxoSmithKline, Dr Gyneth Lourdes G. Bibera discussed on preventive strategies against rotavirus gastroenteritis (RVGE).
Fluarex Tetra - Inactivated quadrivalent influenza vaccine (split virion) vaccine (inj) 0.5 mL - GlaxoSmithKline
Conference Reports
The addition of the first-in-class direct lytic agent exebacase (lysin CF-301) to standard-of-care (SOC) antibiotics demonstrated efficacy against Staphylococcus aureus bacteraemia (SAB), particularly difficult-to-treat methicillin-resistant SA (MRSA), compared with SOC antibiotics alone, according to the results of a phase II trial presented at ECCMID 2019.
The novel human monoclonal antibody suvratoxumab yielded a trend toward reducing the incidence of Staphylococcus aureus pneumonia (SAP) in high-risk, mechanically-ventilated intensive care unit (MV ICU) patients with an acceptable safety profile, according to data from the phase II SAATELLITE* trial presented at ECCMID 2019.
The selective cap-dependent endonuclease inhibitor baloxavir marboxil (hereafter baloxavir) effectively improves influenza symptoms in adolescent patients and those at high risk for influenza complications, according to two subanalyses of the CAPSTONE studies presented at ECCMID 2019.
The novel pleuromutilin antibiotic lefamulin again shows a favourable safety and tolerability profile, now in an oral therapy form for community-acquired bacterial pneumonia (CABP), reveals the LEAP* 2 study.
Many patients prescribed antibiotics for suspected urinary tract infection (UTI) in the emergency department (ED) may not actually require them, according to a single-centre study from the UK presented at ECCMID 2019.
The implementation of point-of-care testing (POCT) for viral respiratory infections in emergency departments could reduce unnecessary hospitalizations and antibiotic treatment, according to a study from the UK.
The airway microbiota is recently demonstrated to be associated with lung cancer via up-regulation of the ERK, PI3K and IL-17A signalling pathways, according to data presented at the recent European Respiratory Society (ERS) International Congress 2018.
